RAP is undoubtedly the the closest comparison that you will find...

RAP is undoubtedly the the closest comparison that you will find on the ASX. Both are start up companies leveraging technologies to solve a medical problem in the emerging telehealth sector. When you read up on various government policies around the world there is a common theme in that all are looking to telehealth to reduce the burden of an ever increasing monetary drain on society from health care. In Australia for instance where people visit the doctor around 11 times per year a trip to the Dr is largely subsidized by the government and would cost the tax payer somewhere around $50. Total taxpayer spend on GP's for 2014 was over $6 billion for instance.

Companies like RAP and EPT have the potential to increase the efficiency of the current medical system and reduce the burden faced by tax payers. They are both setting firm roots to prove the functionality of their respective technologies and in time will both monetise those technologies with ETP on track to commercialise first.

Where they have not aligned to date is in share price action, as I have mentioned several times the technology potential does not set the share price action, share price action is set by those who are being told the story. At a similar point in it's growth RAP began to tell the story very well and was able to move quickly out of the 2c range and gain the support of some fairly hefty US based funds on the way.

EPT appear to be focused more so on delivery of the product which is fine but in the short term less profitable for shareholders